Caris Life Sciences (CAI) Cash from Operations (2024 - 2026)
Caris Life Sciences' (CAI) quarterly Cash from Operations came in at 32876000.0 in Q1 2026, up 204.91% year-on-year from 10782276.54 in Q1 2025, and down 26.58% quarter-over-quarter from 44780000.0 in Q4 2025.
Caris Life Sciences (CAI) Cash from Operations (2024 - 2026) Analysis & Trends
Caris Life Sciences' Cash from Operations history runs 3 years deep, the most recent figure standing at 32876000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 204.91% year-over-year to 32876000.0 in Q1 2026; TTM through Mar 2026 was 147369000.0, a N/A change from a year earlier, with the FY2025 full-year figure at 83155000.0, up 133.91% from the prior year.
- Cash from Operations slipped to 32876000.0 in Q1 2026 per CAI's latest filing, from 44780000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 62425000.0 in Q3 2025 and bottomed at 69427000.0 in Q3 2024.
- The 3-year median for Cash from Operations is 7288000.0 (2025), against an average of 1097571.43.
- Biggest YoY gain for Cash from Operations was 215.05% in 2025; the steepest drop was 189.91% in 2025.
- Year by year, Cash from Operations stood at 38921000.0 in 2024, then surged by 215.05% to 44780000.0 in 2025, then declined by 26.58% to 32876000.0 in 2026.
- Per Business Quant, the three latest CAI Cash from Operations figures stand at 32876000.0 (Q1 2026), 44780000.0 (Q4 2025), and 62425000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Caris Life Sciences | 4.42 Bn | 3.60 Bn | 214.23 Mn | 32.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.88 Mn |
| Mar 31, 2026 | 32.88 Mn |
| Dec 31, 2025 | 44.78 Mn |
| Dec 31, 2025 | 44.78 Mn |
| Sep 30, 2025 | 62.43 Mn |
| Sep 30, 2025 | 62.43 Mn |
| Jun 30, 2025 | 7.29 Mn |
| Jun 30, 2025 | 7.29 Mn |
| Mar 31, 2025 | -31.34 Mn |
| Mar 31, 2025 | -31.34 Mn |
| Dec 31, 2024 | -38.92 Mn |
| Dec 31, 2024 | -38.92 Mn |
| Sep 30, 2024 | -69.43 Mn |
| Sep 30, 2024 | -69.43 Mn |